These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33337376)

  • 1. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological criteria of anti-IgLON5-related tauopathy.
    Gelpi E; Höftberger R; Graus F; Ling H; Holton JL; Dawson T; Popovic M; Pretnar-Oblak J; Högl B; Schmutzhard E; Poewe W; Ricken G; Santamaria J; Dalmau J; Budka H; Revesz T; Kovacs GG
    Acta Neuropathol; 2016 Oct; 132(4):531-43. PubMed ID: 27358064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.
    Erro ME; Sabater L; Martínez L; Herrera M; Ostolaza A; García de Gurtubay I; Tuñón T; Graus F; Gelpi E
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of the anti-IgLON5 disease.
    Gaig C; Graus F; Compta Y; Högl B; Bataller L; Brüggemann N; Giordana C; Heidbreder A; Kotschet K; Lewerenz J; Macher S; Martí MJ; Montojo T; Pérez-Pérez J; Puertas I; Seitz C; Simabukuro M; Téllez N; Wandinger KP; Iranzo A; Ercilla G; Sabater L; Santamaría J; Dalmau J
    Neurology; 2017 May; 88(18):1736-1743. PubMed ID: 28381508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report.
    Pi Y; Zhang LL; Li JC
    Medicine (Baltimore); 2021 Jan; 100(4):e24384. PubMed ID: 33530233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature.
    González-Ávila C; Casado L; Muro García I; Villacieros-Álvarez J; Vivancos J; Quintas S
    Eur J Neurol; 2021 Apr; 28(4):1392-1395. PubMed ID: 33175431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptic Seizures and Right-Sided Hippocampal Swelling as Presenting Symptoms of Anti-IgLON5 Disease: A Case Report and Systematic Review of the Literature.
    Fu Y; Zou X; Liu L
    Front Neurol; 2022; 13():800298. PubMed ID: 35620785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New knowledge on anti-IgLON5 disease.
    Gaig C; Sabater L
    Curr Opin Neurol; 2024 Jun; 37(3):316-321. PubMed ID: 38563128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.
    Nissen MS; Blaabjerg M
    Front Neurol; 2019; 10():1056. PubMed ID: 31632341
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical neurological manifestations in anti-IgLON5 disease: a case report.
    Chen Y; Chen J; Pei Z; Qian W
    Front Neurol; 2024; 15():1340284. PubMed ID: 38450066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.
    Landa J; Gaig C; Plagumà J; Saiz A; Antonell A; Sanchez-Valle R; Dalmau J; Graus F; Sabater L
    Ann Neurol; 2020 Nov; 88(5):1023-1027. PubMed ID: 32740999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of anti-IgLON5 disease].
    Shimohata T; Kimura A
    Rinsho Shinkeigaku; 2021 Dec; 61(12):825-832. PubMed ID: 34789633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy.
    Cagnin A; Mariotto S; Fiorini M; Gaule M; Bonetto N; Tagliapietra M; Buratti E; Zanusso G; Ferrari S; Monaco S
    J Alzheimers Dis; 2017; 59(1):13-20. PubMed ID: 28550263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome.
    Werner J; Jelcic I; Schwarz EI; Probst-Müller E; Nilsson J; Schwizer B; Bloch KE; Lutterotti A; Jung HH; Schreiner B
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.
    Sabater L; Planagumà J; Dalmau J; Graus F
    J Neuroinflammation; 2016 Sep; 13(1):226. PubMed ID: 27586161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
    Grüter T; Möllers FE; Tietz A; Dargvainiene J; Melzer N; Heidbreder A; Strippel C; Kraft A; Höftberger R; Schöberl F; Thaler FS; Wickel J; Chung HY; Seifert F; Tschernatsch M; Nagel M; Lewerenz J; Jarius S; Wildemann BC; de Azevedo L; Heidenreich F; Heusgen R; Hofstadt-van Oy U; Linsa A; Maaß JJ; Menge T; Ringelstein M; Pedrosa DJ; Schill J; Seifert-Held T; Seitz C; Tonner S; Urbanek C; Zittel S; Markewitz R; Korporal-Kuhnke M; Schmitter T; Finke C; Brüggemann N; Bien CI; Kleiter I; Gold R; Wandinger KP; Kuhlenbäumer G; Leypoldt F; Ayzenberg I;
    Brain; 2023 Feb; 146(2):600-611. PubMed ID: 35259208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.
    Ono Y; Tadokoro K; Yunoki T; Yamashita T; Sato D; Sato H; Akamatsu S; Mizukami H; Ohta Y; Yamano Y; Kimura A; Shimohata T
    Parkinsonism Relat Disord; 2024 Jul; 124():106992. PubMed ID: 38701719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.